[1] | Li B, Zhao Y, Liu C, Chen Z, Zhou D . Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol, 2014,9(9):1071-1081. | [2] | Swathi CH, Chikala R, Ratnakar KS, Sritharan V . A structural, epidemiological & genetic overview of Klebsiella pneumoniae carbapenemases (KPCs). Indian J Med Res, 2016,144(1):21-31. | [3] | Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, Vamvakopoulou S, Filos KS, Anastassiou ED . Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis, 2014,46(9):642-648. | [4] | Karaiskos I, Giamarellou H . Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother, 2014,15(10):1351-1370. | [5] | Tangdén T, Giske CG . Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med, 2015,277(5):501-512. | [6] | Robilotti E, Deresinski S . Carbapenemase-producing Klebsiella pneumoniae. F1000Prime Rep, 2014,6:80. | [7] | Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 27th informational supplement.Standard: CLSI-M100- S27. | [8] | J.萨姆布鲁克(SambrookJ.), D.W.拉塞尔. 分子克隆实验指南(第三版). 黄培堂等译, 2002, 北京: 科学出版社. | [9] | Delcher AL, Bratke KA, Powers EC, Salzberg SL . Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics, 2007,23(6):673-679. | [10] | Posada D. Using MODELTEST and PAUP* to select a model of nucleotide substitution. Curr Protoc Bioinformatics, 2003, Chapter 6: Unit6.5. | [11] | Xu T, Ying J, Yao XD, Song YL, Ma P, Bao BK, Jiang WY, Wu XM, Tou HF, Li PZ, Ren P, Fei JX, Yang L, Liu Q, Xu ZY, Zhou TL, Ni LY, Bao QY . Identification and characterization of two novel bla(KLUC) resistance genes through large-scale resistance plasmids sequencing. PLoS One, 2012,7(10):e47197. | [12] | Rice LB, Carias LL, Bonomo RA, Shlaes DM . Molecular genetics of resistance to both ceftazidime and beta-lactam- beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy. J Infect Dis, 1996,173(1):151-158. | [13] | Zhang YJ, Chang QL, Wang Q, Lu JW, Wang H, Li PZ, Ying J, Bao QY, Hu YL . Structure and function of class 1 integron in clinical isolates of Klebsiella pneumoniae. Hereditas (Beijing), 2014,36(6):603-610. | [13] | 张跃进, 常清利, 汪倩, 卢俊婉, 王欢, 李佩珍, 应俊, 包其郁, 胡云良 . 临床分离肺炎克雷伯菌Ⅰ类整合子的结构与功能. 遗传, 2014,36(6):603-610. | [14] | Mathers AJ, Peirano G, Pitout JD . The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev, 2015,28(3):565-591. | [15] | Bush K, Jacoby GA, Medeiros AA . A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995,39(6):1211-1233. | [16] | Chen X, Fan XJ, Lv XJ . Progress of the classification of β-lactamases and its relationship between structure and function. J Chin Pharm Univ, 2003,34(4):380-384. | [16] | 陈炫, 范昕建, 吕晓菊 . β-内酰胺酶的分类及构效关系研究进展. 中国药科大学学报. 2003,34(4):380-384. | [17] | Fonseca EL, Vieira VV, Cipriano R, Vicente AC . Emergence of dhfrXVb and blaCARB-4 gene cassettes in class 1 integrons from clinical Pseudomonas aeruginosa isolated in Amazon region. Mem Inst Oswaldo Cruz, 2006,101(1):81-84. | [18] | Li R, Chiou J, Chan EW, Chen S . A novel PCR-based approach for accurate identification of Vibrio parahaemolyticus. Front Microbiol, 2016,7:44. | [19] | Kamolvit W, Derrington P, Paterson DL, Sidjabat HE . A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in Australia. J Clin Microbiol, 2015,53(2):727-730. | [20] | Zhang RQ, Ying GG, Su HC, Zhou LJ, Liu YS . Antibiotic resistance and genetic diversity of Escherichia coli isolates from traditional and integrated aquaculture in South China. J Environ Sci Health B, 2013,48(11):999-1013. | [21] | Schultz E, Barraud O, Madec JY, Haenni M, Cloeckaert A, Ploy MC, Doublet B. Multidrug resistance salmonella genomic island 1 in a Morganella morganii subsp. morganiihuman clinical isolate from France. mSphere, 2017, 2(2): pii:e00118-17. | [22] | Philippon AM, Paul GC, Thabaut AP, Jacoby GA . Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1986,29(3):519-520. | [23] | Melano R, Petroni A, Garutti A, Saka HA, Mange L, Pasteran F, Rapoport M, Rossi A, Galas M . New carbenicillin-hydrolyzing beta-lactamase (CARB-7) from Vibrio cholerae non-O1, non-O139 strains encoded by the VCR region of the V. cholerae genome. Antimicrob Agents Chemother, 2002,46(7):2162-2168. | [24] | Petroni A, Melano RG, Saka HA, Garutti A, Mange L, Pasteran F, Rapoport M, Miranda M, Faccone D, Rossi A, Hoffman PS, Galas MF . CARB-9, a carbenicillinase encoded in the VCR region of Vibrio cholerae non-O1, non-O139 belongs to a family of cassette-encoded beta-lactamases. Antimicrob Agents Chemother, 2004,48(10):4042-4046. | [25] | Hu LF, Chen GS, Kong QX, Gao LP, Chen X, Ye Y, Li JB . Increase in the prevalence of resistance determinants to Trimethoprim/Sulfamethoxazole in clinical S tenotrophomonasmaltophiliaisolates in China. PLoS One, 2016,11(6):e0157693. | [26] | Meng XF, Zhang ZF, Li KT, Wang Y, Xia XD, Wang X, Xi ML, Meng JH, Cui SH, Yang BW . Antibiotic susceptibility and molecular screening of class I integronin Salmonellaisolates recovered from retail raw chicken carcasses in China. Microb Drug Resist, 2017,23(2):230-235. |
|